comprehensive -WSS

comprehensive

author：focus 2025-09-27 12:55:48 - browse：2495

The home health industry lobbying group is suing Medicare over new payment cuts. But profits in the sector remain near all-time highs. Business Insider/AP

The National Association of Home Care and Hospice sued the Biden administration to halt the government’s recent proposed rule that would cut Medicare payments to home health agencies by 2.2% in 2024.

Since 2020, Medicare has updated its system for how it pays for home health, in particular by basing payments less on how much therapy someone is getting at home. By law, the new system can’t cost more or less than it otherwise would have, but Medicare reinforced this year that it had “paid more under the new system than it would have under the old system” — and thus continued cuts to home health for next year.

Newsletters

Sign up for STAT Health Care Inc.

Following the flow of money through the health care industry.

Please enter a valid email address. Privacy Policy

NAHC, the home health industry’s lobbying group, said in its lawsuit that Medicare has been violating the requirement to keep things “budget-neutral” and threatens to put home health operators out of business. But one thing NAHC failed to mention: Profits in the home health industry remain near all-time highs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Questions and answers about ramping up H5N1 bird flu vaccine

WSS

H5N1 virus can be tracked in retail milk, scientists say

Biogen joins immunology wave with $1.15 billion acquisition of HI

Intellia plays down concerns on accidental germline transmission

PBMs are inflating the cost of generic drugs. They must be reined in

California store owner shot dead in dispute over displaying Pride flag: Police

Investigation reveals sickle cell patients pressured into sterilizations

focus

comprehensive

Sign up for STAT Health Care Inc.

entertainment

The high cost of giving birth even with insurance

DeSantis wants to import drugs. Biden’s FDA blasted his plan

State Dept. review finds Biden bears some blame for Afghanistan failures

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Hepatitis C has a cure — but many Americans still lack access to it

Listen: Vivek Ramaswamy's star turn & leaky drug data

Drug repurposing or repositioning? The language matters

As obesity drug market grows, telehealth companies court payers

How one medical school became remarkably diverse

Can U.S. cancer drug shortages be fixed?

Wikipedia

Listen: Vivek Ramaswamy's star turn & leaky drug data

Republicans love RFK Jr. What's that tell us about health in 2024?

Trans patients at the end of life deserve respect and dignity

Roche's accidental data boosts hopes for anti

FDA poised to publish guidelines for clinical trial diversity

PBMs are inflating the cost of generic drugs. They must be reined in

entertainment

focus

leisure time

focus